Dr. Ram Aiyar is the CEO of Korro Bio, Inc., a company focused on innovative biopharmaceutical solutions. He has a strong educational background with an MBA from INSEAD, a PhD from Drexel University, and a bachelor's degree in electronics engineering...

Dr. Ram Aiyar is the CEO of Korro Bio, Inc., a company focused on innovative biopharmaceutical solutions. He has a strong educational background with an MBA from INSEAD, a PhD from Drexel University, and a bachelor's degree in electronics engineering from Mumbai University. Before leading Korro, he co-founded Corvidia Therapeutics, where he also served as the Chief Financial Officer. Aiyar has experience in various leadership roles in corporate development and product management for companies like Johnson & Johnson and J.P. Morgan. He is currently involved in insider trading activities that reflect his confidence in Korro Bio, showing a range of stock value fluctuations from about $6.21 million in November 2023 to $11.43 million in April 2024. His new employment agreement includes a base salary of $498,487 with a target bonus tied to performance, indicating a strong alignment with company growth and strategy. Dr. Aiyar's career reflects a blend of deep knowledge in biopharmaceutical processes and practical business strategy, making him well-suited to guide Korro in its mission to innovate in the healthcare space.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Korro Bio, Inc. CEOs

K

Ram Aiyar, Ph.D., M.B.A.

Founder and CEO of Korro Bio, Inc.

Education

MBA in finance and business strategy from INSEAD, MS in computer engineering, PhD in electrical and computer engineering from Drexel University, BE in electronics engineering from Mumbai University.

Sector of Economy

Healthcare

CEO of Korro Bio, Inc. for

1 year 7 months (Nov 2023 - Present)

Previous Experience

Co-founder of Corvidia Therapeutics, former CEO and director roles in various biopharmaceutical companies.

Rivals

Competitors/colleagues of Ram Aiyar, Ph.D., M.B.A.

Holdings

See how much did Ram Aiyar, Ph.D., M.B.A. make over time.

Dr. Aiyar's holdings in Korro Bio reflect significant confidence in the company's future, with insider trading activity showcasing ups and downs in stock value. His stake was valued at $6.21 million in November 2023 and peaked at $11.43 million by...

Dr. Aiyar's holdings in Korro Bio reflect significant confidence in the company's future, with insider trading activity showcasing ups and downs in stock value. His stake was valued at $6.21 million in November 2023 and peaked at $11.43 million by April 2024. This increase suggests positive market reactions to the company’s strategies and developments. His holdings illustrate a personal investment in the company's mission, aligning his financial success with Korro's growth. With a base salary of $498,487, Aiyar has significant incentives linked to performance metrics, reflecting a commitment to enhancing shareholder value in the rapidly evolving biopharmaceutical landscape. Investing in Korro’s shares is indicative of both personal confidence and strategic foresight in a competitive marketplace.

Mar 18, 2025

K

shares

KRRO @ $24.17

Insider Trading

See recent insider trades of Ram Aiyar, Ph.D., M.B.A..

KRRO

4,613 shares

KRRO

Nov 3, 2023

Received

Compensation History

See how much did Ram Aiyar, Ph.D., M.B.A. make over time.

In 2023, Dr. Ram Aiyar's total compensation as CEO of Korro Bio was $835,966. His base salary stood at $498,487, supplemented by about $336,479 in additional benefits, but no annual bonus or stock options were granted this year. Aiyar's pay package reflects a focus on aligning his earnings with the performance of the company, intending to incentivize growth and ambition. His target bonus opportunity is set at 45% of his base salary, which ties into both individual and company-wide achievements. This structure emphasizes a pay-for-performance philosophy, aiming to motivate Aiyar toward strategic goals that propel Korro Bio forward in the competitive biopharmaceutical industry.

Year

2023

Total Compensation

$834.97K

Salary

$498.49K

Board Justification

The compensation philosophy focuses on aligning executive pay with company performance and market benchmarks to retain talent and drive long-term growth.

Bonus

$0.00

Board Justification

No annual bonus was awarded for 2023.

Other

$336.48K

Board Justification

This includes matching contributions to the 401(k) account and other benefits.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock awards were vested in 2023.

Performance Metrics

The performance metrics for determining compensation include individual performance and overall company performance.

Other Korro Bio, Inc. CEOs

Here are other CEOs of Korro Bio, Inc.

David L. Lucchino

Founder and Ex-CEO of Korro Bio, Inc.

November 2014 - November 2023